Click Image To Visit Site1) Asvold BO., “Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study.” Arch Intern Med. 2008 Apr 28;168(8):855-60. 2) Asvold BO., “The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study” Eur J Endocrinol February 1, 2007 156 181-186. 3) Baisier, W. V., “Thyroid Insufficiency. Is Thyroxine the Only Valuable Drug?” Journal of Nutritional & Environmental Medicine. (2001), 11, 159-166. 4) Carvalho, D. P., “Thyroid peroxidase activity is inhibited by amino acids” Brazilian Journal of Medical and Biological Research. 2000 Mar;33(3):355-61. 5) Fukusen N.,”Inhibition of chymase activity by phosphoglycerides.” Archives of Biochemistry and Biophysics. 1985 Feb 15;237(1):118-23. 6) Chopra I.J., “Evidence for an inhibitor of extrathyroidal conversion of thyroxine to 3,5,3′-triiodothyronine in sera of patients with nonthyroidal illnesses.” The journal of clinical endocrinology and metabolism. 1985 Apr;60(4):666-72. 7) Tabachnick M., “Effect of long-chain fatty acids on the binding of thyroxine and triiodothyronine to human thyroxine-binding globulin.” Biochimica et Biophysica Acta. 1986 Apr 11;881(2):292-6. 8) Wiersinga W.M., “Inhibition of nuclear T3 binding by fatty acids.” Metabolism. 1988 Oct;37(10):996-1002. 9) Rafael J. “The effect of essential fatty acid deficiency on basal respiration and function of liver mitochondria in rats.” The journal of nutrition. 1984 Feb;114(2):255-62. 10) Fery, F., “Hormonal and metabolic changes induced by an isocaloric isoproteinic ketogenic diet in healthy subjects.” Diabetes and Metabolism. 1982 Dec;8(4):299-305. 11) Orzechowska-Pawiłojć, A., “The influence of thyroid hormones on homocysteine and atherosclerotic vascular disease” Endokrynol Pol. 2005 Mar-Apr;56(2):194-202. 12) Ramsden C.E., “Use of dietary… Read more…